| Dr Jeffrey Charles Hatcher, MD | |
|
301 E Wendover Ave, Suite 111, Greensboro, NC 27401-1230 | |
| (336) 832-7840 | |
| Not Available |
| Full Name | Dr Jeffrey Charles Hatcher |
|---|---|
| Gender | Male |
| Speciality | Internal Medicine |
| Experience | 30 Years |
| Location | 301 E Wendover Ave, Greensboro, North Carolina |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1457308918 | NPI | - | NPPES |
| 89129HN | Medicaid | NC | |
| 129HN | Other | NC | BCBS NC |
| 7861244 | Other | NC | AETNA |
| B2108 | Other | NC | MEDCOST |
| 44773 | Other | NC | PARTNERS MEDICARE CHOICE |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RI0200X | Internal Medicine - Infectious Disease | 200100888 (North Carolina) | Primary |
| 207R00000X | Internal Medicine | 200100888 (North Carolina) | Secondary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Moses H. Cone Memorial Hospital, The | Greensboro, NC | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| The Moses H Cone Memorial Hospital Operating Corporation | 6204744600 | 496 |
News Archive
With the continuing advance of technology, radio tracking devices keep getting smaller and smaller. And that's bad news for stealthy insects like kissing bugs.
PURE Bioscience, creators of the patented silver dihydrogen citrate (SDC) antimicrobial, announced today that it has sold $2.376 million of its common stock in an unregistered private placement solely to non-affiliated accredited investors.
According to a study by Stanford University School of Medicine, Celebrex causes fewer gastrointestinal complications than traditional nonsteroidal anti-inflammatory painkillers or NSAIDs in osteoarthritis patients and does not increase the risk of heart attacks.
Today's headlines include a variety of reports about the health law's implementation as well as related developments from Capitol Hill.
› Verified 1 days ago
| Entity Name | The Moses H Cone Memorial Hospital Operating Corporation |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1356372064 PECOS PAC ID: 6204744600 Enrollment ID: O20031124000541 |
News Archive
With the continuing advance of technology, radio tracking devices keep getting smaller and smaller. And that's bad news for stealthy insects like kissing bugs.
PURE Bioscience, creators of the patented silver dihydrogen citrate (SDC) antimicrobial, announced today that it has sold $2.376 million of its common stock in an unregistered private placement solely to non-affiliated accredited investors.
According to a study by Stanford University School of Medicine, Celebrex causes fewer gastrointestinal complications than traditional nonsteroidal anti-inflammatory painkillers or NSAIDs in osteoarthritis patients and does not increase the risk of heart attacks.
Today's headlines include a variety of reports about the health law's implementation as well as related developments from Capitol Hill.
› Verified 1 days ago
| Entity Name | Alamance Regional Medical Center Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1326010273 PECOS PAC ID: 5294647145 Enrollment ID: O20040504000878 |
News Archive
With the continuing advance of technology, radio tracking devices keep getting smaller and smaller. And that's bad news for stealthy insects like kissing bugs.
PURE Bioscience, creators of the patented silver dihydrogen citrate (SDC) antimicrobial, announced today that it has sold $2.376 million of its common stock in an unregistered private placement solely to non-affiliated accredited investors.
According to a study by Stanford University School of Medicine, Celebrex causes fewer gastrointestinal complications than traditional nonsteroidal anti-inflammatory painkillers or NSAIDs in osteoarthritis patients and does not increase the risk of heart attacks.
Today's headlines include a variety of reports about the health law's implementation as well as related developments from Capitol Hill.
› Verified 1 days ago
| Entity Name | Moses Cone Physician Services, Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1093953127 PECOS PAC ID: 4284782210 Enrollment ID: O20090501000202 |
News Archive
With the continuing advance of technology, radio tracking devices keep getting smaller and smaller. And that's bad news for stealthy insects like kissing bugs.
PURE Bioscience, creators of the patented silver dihydrogen citrate (SDC) antimicrobial, announced today that it has sold $2.376 million of its common stock in an unregistered private placement solely to non-affiliated accredited investors.
According to a study by Stanford University School of Medicine, Celebrex causes fewer gastrointestinal complications than traditional nonsteroidal anti-inflammatory painkillers or NSAIDs in osteoarthritis patients and does not increase the risk of heart attacks.
Today's headlines include a variety of reports about the health law's implementation as well as related developments from Capitol Hill.
› Verified 1 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Jeffrey Charles Hatcher, MD 1200 N Elm St, Greensboro, NC 27401-1004 Ph: (336) 832-7000 | Dr Jeffrey Charles Hatcher, MD 301 E Wendover Ave, Suite 111, Greensboro, NC 27401-1230 Ph: (336) 832-7840 |
News Archive
With the continuing advance of technology, radio tracking devices keep getting smaller and smaller. And that's bad news for stealthy insects like kissing bugs.
PURE Bioscience, creators of the patented silver dihydrogen citrate (SDC) antimicrobial, announced today that it has sold $2.376 million of its common stock in an unregistered private placement solely to non-affiliated accredited investors.
According to a study by Stanford University School of Medicine, Celebrex causes fewer gastrointestinal complications than traditional nonsteroidal anti-inflammatory painkillers or NSAIDs in osteoarthritis patients and does not increase the risk of heart attacks.
Today's headlines include a variety of reports about the health law's implementation as well as related developments from Capitol Hill.
› Verified 1 days ago
Dr. Olugbemiga Ebenezer Jegede, M.D Infectious Disease Medicare: Accepting Medicare Assignments Practice Location: 201 E Wendover Ave, Greensboro, NC 27401 Phone: 336-832-4444 Fax: 336-832-4445 | |
Yan Feng, Infectious Disease Medicare: Accepting Medicare Assignments Practice Location: 501 N Elam Ave, Greensboro, NC 27403 Phone: 336-832-1100 | |
Dr. Gary Bradley Sherrill, M.D. Infectious Disease Medicare: Accepting Medicare Assignments Practice Location: 501 N Elam Ave, Greensboro, NC 27403 Phone: 336-832-1100 | |
Edwin Aziegbe Avbuere, MD Infectious Disease Medicare: Accepting Medicare Assignments Practice Location: 3231 Yanceyville Street, Greensboro, NC 27405 Phone: 336-358-1528 Fax: 336-358-1582 | |
Dr. Jay Krishnavadan Patel, MB.CHB Infectious Disease Medicare: Accepting Medicare Assignments Practice Location: 309 New St, Carolina Kidney Associates, Greensboro, NC 27405 Phone: 336-379-9708 Fax: 336-553-2085 | |
Gayatri A Acharya, MD Infectious Disease Medicare: Accepting Medicare Assignments Practice Location: 3200 Northline Ave Ste 250, Greensboro, NC 27408 Phone: 336-273-7900 | |
Murali Ramaswamy, MD FAAFP Infectious Disease Medicare: Accepting Medicare Assignments Practice Location: 520 N Elam Ave, Greensboro, NC 27403 Phone: 336-547-1801 Fax: 336-547-1828 |